AstraZeneca is a leading global biopharmaceutical company, headquartered in Cambridge and with a deep-rooted commitment to the UK.
As a company dedicated to improving public health by delivering effective treatments, we pride ourselves on fostering a distinct culture of innovation and a commitment to sustainability – with a focus on broadening access to healthcare. We help treat approximately one million patients in the UK every year with cancer; cardiovascular, renal and metabolic diseases, such as heart failure and diabetes; and respiratory conditions, such as asthma and chronic obstructive pulmonary disease.
As one of the largest private investors in life sciences R&D, science and collaboration are at the heart of how we deliver innovative medicines for patients and value to the NHS